Trust is priceless - Partnership is our most valuable resource

At SMD, we are passionate about working with medical device manufacturers who share our vision of making a positive impact on patient outcomes. Our team of experts is committed to sourcing and partnering with medical device manufacturers to bring unique solutions to the UK Healthcare system.

We understand the importance of delivering high-quality, reliable, and cost-effective products that meet the needs of patients and healthcare providers. Delivering products for Value Based Health Care (VBHC) is why ScottMed was founded.

“Value-based healthcare is the equitable, sustainable and transparent use of the available resources to achieve better outcomes and experiences for every person”.

If you’re a medical device manufacturer looking to make a difference and improve patient outcomes, we would love to work with you. Get in touch with us today to see how we can help bring your vision to life.

Based in Ontario, Canada, SterileCare develops preventative and treatment-related solutions to fight against the threat of serious infections.  SterileCare aims to provide preventative and treatment related solutions through research and collaborations with healthcare professionals thereby improving the quality of patient care.

KiteLock 4% is the only non-antibiotic, antimicrobial solution with the capability to eradicate biofilm of all relevant bacterial strains and yeast including superbugs. (eg. MRSA, etc.). KiteLock 4% solution was effective at eradicating surface-attached biofilms from Gram-positive, Gram-negative, and fungal species, to prevent biofilm growth within CVADs and to eliminate established biofilms.

[Please click link below to SterileCare’s website for clinical references]

The Triple Threat are three interrelated processes occurring inside a CVAD. Blood forms a clot inside the catheter lumen. Clots feed microorganisms. Microorganisms create biofilm. Biofilm is a sticky surface promoting clot adherence. The three gears must be knocked out to avoid further CVAD complications or the cycle repeats.